Probiotics improve atopic dermatitis in children and adolescents: a double blind, placebo-controlled study.

Controlled Study ◽

Double Blind ◽

The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study

British Journal of Dermatology ◽

10.1111/bjd.20690 ◽

2021 ◽

Author(s):

Y. Zhao ◽

L. Wu ◽

Q. Lu ◽

X. Gao ◽

X. Zhu ◽

...

Keyword(s):

Atopic Dermatitis ◽

Chinese Patients ◽

Controlled Study ◽

Severe Atopic Dermatitis ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.10.006 ◽

2017 ◽

Vol 56 (12) ◽

pp. 1015-1025 ◽

Cited By ~ 35

Author(s):

Melissa P. DelBello ◽

Robert Goldman ◽

Debra Phillips ◽

Ling Deng ◽

Josephine Cucchiaro ◽

...

Keyword(s):

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

A Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine in Japanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2008.0154 ◽

2009 ◽

Vol 19 (4) ◽

pp. 341-350 ◽

Cited By ~ 26

Author(s):

Michihiro Takahashi ◽

Yasushi Takita ◽

Kosuke Yamazaki ◽

Takashi Hayashi ◽

Hironobu Ichikawa ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Controlled Study ◽

Japanese Children ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2013.12.1068 ◽

2014 ◽

Vol 133 (2) ◽

pp. AB404 ◽

Cited By ~ 2

Author(s):

Thomas R.M. Bieber ◽

Diamant Thaci ◽

Neil Graham ◽

Gianluca Pirozzi ◽

Ariel Teper ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Study ◽

Severe Atopic Dermatitis ◽

Double Blind ◽

Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2018.07.007 ◽

2018 ◽

Vol 40 ◽

pp. 22-28 ◽

Cited By ~ 1

Author(s):

Jin Hyang Ahn ◽

Younghee Yun ◽

Min Hee Kim ◽

Seoung-Gyu Ko ◽

Kyu Seok Kim ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000205709.63571 ◽

2006 ◽

Vol PAP ◽

Author(s):

LAURENCE L. GREENHILL ◽

JOSEPH BIEDERMAN ◽

SAMUEL W. BOELLNER ◽

THOMAS A. RUGINO ◽

R. BART SANGAL ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study

British Journal of Dermatology ◽

10.1111/bjd.17932 ◽

2019 ◽

Vol 181 (4) ◽

pp. 733-742 ◽

Cited By ~ 28

Author(s):

R. Bissonnette ◽

C. Maari ◽

S. Forman ◽

N. Bhatia ◽

M. Lee ◽

...

Keyword(s):

Atopic Dermatitis ◽

Tyrosine Kinase ◽

Systemic Inflammation ◽

Janus Kinase ◽

Controlled Study ◽

Severe Atopic Dermatitis ◽

Spleen Tyrosine Kinase ◽

Double Blind ◽

Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind Placebo-Controlled Study

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70051-3 ◽

2006 ◽

Vol 2006 ◽

pp. 48-49

Author(s):

P.S. Jensen

Keyword(s):

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Fluoxetine Treatment ◽

Prevention Of Relapse

Faculty of 1000 evaluation for A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with tourette's disorder.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718129292.793486633 ◽

2013 ◽

Author(s):

Cynthia Comella

Keyword(s):

Controlled Study ◽

Tourette’S Disorder ◽

Double Blind ◽

Double Blind Placebo ◽

Tourette's Disorder

Faculty Opinions recommendation of The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725811120.793513059 ◽

2016 ◽

Author(s):

Hidehisa Saeki

Keyword(s):

Atopic Dermatitis ◽

Single Dose ◽

Healthy Volunteers ◽

Controlled Study ◽

Double Blind ◽